PATHOGENESIS OF R5 HIV-1 ISOLATES
PATHOGENESIS OF R5 HIV-1 ISOLATES
批准号:
6511307
负责人:
DAVID CAMERINI
金额:
$28.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-07-01 至 2002-12-31
中文摘要
描述(来自申请人的摘要):这是一份由Dr.
来自弗吉尼亚大学的大卫·卡梅里尼研究了CCR 5的作用--热带
HIV-1在HIV发病机制中的作用申请人将使用SCID-hu小鼠
人胸腺/肝移植模型,以研究
这些隔离物。既往表征的R5 HIV-1分离株来自于
艾滋病前和艾滋病阶段的HIV-1感染将被评估的分子
SCID-hu模型发病的决定因素和机制。R5-艾滋病前
HIV-I分离株对胸腺细胞无细胞病变,而R5-AIDS分离株引起
SCID-hu模型中胸腺细胞的耗竭。具体目标1是绘制
R5-AIDS的区域,其通过发展重组体而赋予致病性,
传染性病毒最初,重点将放在包膜基因上,因为它
具有细胞嗜性和细胞病变的分子决定因素。的
有待检验的假设是,env基因的变化解释了
增加这些分离株的致病潜力。具体目标2将
测试这些基因变化可能导致亲和力增加的假设,
CCR 5和/或R5-AIDS分离株扩大的共受体使用。的
将测试重组病毒的受体使用。具体目标3
将测试HIV-1通过CCR 5介导的信号传导将允许
静息记忆T细胞和一些胸腺细胞的感染。
英文摘要
DESCRIPTION (from applicant's abstract): This is a revised application by Dr.
David Camerini from the University of Virginia to study the role of CCR5-tropic
HIV-1 isolates in HIV pathogenesis. The applicant will use the SCID-hu mouse
model bearing human thymus/liver grafts to study the pathogenic effects of
these isolates. Previously characterized R5 HIV-1 isolates from patients during
pre-AIDS and AIDS stages of HIV-1 infection will be evaluated for the molecular
determinants and mechanisms of pathogenesis in SCID-hu model. The R5-pre AIDS
HIV-I isolates are not cytopathic to thymocytes whereas R5-AIDs isolates cause
depletion of thymocytes in the SCID-hu model. The Specific aim 1 will be to map
the regions of R5-AIDS which confer pathogenicity by developing recombinant
infectious viruses. Initially, the focus will be on the envelope gene since it
harbors molecular determinants for cell tropism and cytopathicity. The
hypothesis to be tested is that changes in the env gene account for the
increase in pathogenic potential of these isolates. The Specific aim 2 will
test the hypothesis that these genetic changes could lead to increased affinity
to CCR5 and/or broadened co-receptor usage by the R5-AIDs isolates. The
recombinant viruses will be tested for the receptor usage. The Specific aim 3
will test the hypothesis that HIV-1 mediated signaling through CCR5 will allow
infection of resting memory T cells and some thymocytes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of Serodiagnostic Epitopes for SARS-CoV-2, endemic HCoV?s and influenza virus
-
批准号:10259177
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2021
-
负责人:DAVID CAMERINI
-
依托单位:
Discovery of Yellow Fever Virus-Specific Epitopes for Development of an Accurate Serodiagnostic Assay
-
批准号:9467246
-
项目类别:
-
资助金额:$29.96万
-
财政年份:2018
-
负责人:DAVID CAMERINI
-
依托单位:
Specific Detection of Antibodies to Emerging and Established Arboviruses Including Zika Virus
-
批准号:9347926
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2017
-
负责人:DAVID CAMERINI
-
依托单位:
Point of Care Detection of Oral Pathogens
-
批准号:8973923
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2015
-
负责人:DAVID CAMERINI
-
依托单位:
Development of a Pan-HIV Proteomic Chip
-
批准号:8659860
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2014
-
负责人:DAVID CAMERINI
-
依托单位:
HIV Pathogenesis and Immunity in Viremic Non-Progressors
-
批准号:8069963
-
项目类别:
-
资助金额:$18.97万
-
财政年份:2010
-
负责人:DAVID CAMERINI
-
依托单位:
HIV Pathogenesis and Immunity in Viremic Non-Progressors
-
批准号:7931065
-
项目类别:
-
资助金额:$22.98万
-
财政年份:2010
-
负责人:DAVID CAMERINI
-
依托单位:
Defensin mediated inhibition of HIV-1 replication
-
批准号:6954219
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2004
-
负责人:DAVID CAMERINI
-
依托单位:
Defensin mediated inhibition of HIV-1 replication
-
批准号:6845911
-
项目类别:
-
资助金额:$22.76万
-
财政年份:2004
-
负责人:DAVID CAMERINI
-
依托单位:
HIV-1 Clones with Attenuated Cytopathic Effects
-
批准号:6744170
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2003
-
负责人:DAVID CAMERINI
-
依托单位:
HIV-1 Clones with Attenuated Cytopathic Effects
-
批准号:6655454
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2003
-
负责人:DAVID CAMERINI
-
依托单位:
PATHOGENESIS OF R5 HIV-1 ISOLATES
-
批准号:6740219
-
项目类别:
-
资助金额:$31.41万
-
财政年份:2000
-
负责人:DAVID CAMERINI
-
依托单位:
PATHOGENESIS OF R5 HIV-1 ISOLATES
-
批准号:6374535
-
项目类别:
-
资助金额:$25.67万
-
财政年份:2000
-
负责人:DAVID CAMERINI
-
依托单位:
PATHOGENESIS OF R5 HIV-1 ISOLATES
-
批准号:6608017
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2000
-
负责人:DAVID CAMERINI
-
依托单位:
PATHOGENESIS OF R5 HIV-1 ISOLATES
-
批准号:6213536
-
项目类别:
-
资助金额:$30.66万
-
财政年份:2000
-
负责人:DAVID CAMERINI
-
依托单位:
PATHOGENESIS OF R5 HIV-1 ISOLATES
-
批准号:6554505
-
项目类别:
-
资助金额:$2.99万
-
财政年份:2000
-
负责人:DAVID CAMERINI
-
依托单位:
TESTING ANTIHIV-1 GENE THERAPY IN SCID-HU MICE
-
批准号:2429507
-
项目类别:
-
资助金额:$11.33万
-
财政年份:1996
-
负责人:DAVID CAMERINI
-
依托单位:
TESTING ANTIHIV-1 GENE THERAPY IN SCID-HU MICE
-
批准号:6169936
-
项目类别:
-
资助金额:$7.55万
-
财政年份:1996
-
负责人:DAVID CAMERINI
-
依托单位:
TESTING ANTIHIV-1 GENE THERAPY IN SCID-HU MICE
-
批准号:2076892
-
项目类别:
-
资助金额:$11.33万
-
财政年份:1996
-
负责人:DAVID CAMERINI
-
依托单位:
TESTING ANTIHIV-1 GENE THERAPY IN SCID-HU MICE
-
批准号:2672777
-
项目类别:
-
资助金额:$11.33万
-
财政年份:1996
-
负责人:DAVID CAMERINI
-
依托单位:
海外基金